Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cardiotoxicity × Plasma cell × Clear all

Status

Terminated 2 Recruiting 2 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 30 Lymphoid 15 Other hematologic neoplasm 7 Thoracic 5 Sarcoma 4 Gastrointestinal 3 Plasma cell 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Multiple Myeloma 1470 Neoplasms, Plasma Cell 362 Lymphoma, Non-Hodgkin 275 Lymphoma 250 Hodgkin Disease 244 Leukemia, Lymphocytic, Chronic, B-Cell 236 Precursor Cell Lymphoblastic Leukemia-Lymphoma 208 Leukemia 194 Leukemia, Myeloid, Acute 190 Myelodysplastic Syndromes 170 Lymphoma, Mantle-Cell 168 Lymphoma, Follicular 167 Lymphoma, Large B-Cell, Diffuse 166 Recurrence 162 Lymphoma, B-Cell, Marginal Zone 149 Burkitt Lymphoma 146 Lymphoma, Large-Cell, Immunoblastic 139 Myeloproliferative Disorders 129 Leukemia, Myeloid, Chronic-Phase 112 Primary Myelofibrosis 106 Leukemia, Myeloid, Accelerated Phase 104 Lymphoma, T-Cell, Cutaneous 103 Immunoglobulin Light-chain Amyloidosis 103 Blast Crisis 99 Waldenstrom Macroglobulinemia 97 Leukemia, Myelomonocytic, Chronic 92 Sezary Syndrome 84 Neoplasms 84 Mycosis Fungoides 84 Leukemia, Hairy Cell 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02178579 2020-09-14

PROTECT

Vanderbilt University Medical Center

Heart Failure, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡